[{"source": "wsj", "link": "https://www.wsj.com/articles/the-u-s-shifts-focus-to-venezuelan-oil-but-output-is-low-11646694776", "title": "The U.S. Shifts Focus to Venezuelan Oil, but Output Is Low", "date": "2022-03-07 18:12", "summary": "Even if the U.S. lifts sanctions on Venezuela, years of mismanagement and nationalizations have made Venezuelan production just a fraction of what it was in the 1990s. BOGOTA, Colombia-Even as the U.S. considers lifting sanctions so Venezuela gets oil flowing, the reality is that the country's oil sector is ill-prepared to start churning out more crude and lower fast-rising oil prices amid the Ukraine war.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"The U.S. Shifts Focus to Venezuelan Oil, but Output Is Low. Even if the U.S. lifts sanctions on Venezuela, years of mismanagement and nationalizations have made Venezuelan production just a fraction of what it was in the 1990s. BOGOTA, Colombia-Even as the U.S. considers lifting sanctions so Venezuela gets oil flowing, the reality is that the country's oil sector is ill-prepared to start churning out more crude and lower fast-rising oil prices amid the Ukraine war.\"\n\nStock Prediction(s):", "Prediction": "\n- Chevron Corporation (NYSE: CVX) will increase because they have a lot of experience in the Venezuelan oil sector, and they are well-prepared to increase production.\n- Exxon Mobil Corporation (NYSE: XOM) will increase because they have a lot of experience in the Venezuelan oil sector, and they are well-prepared to increase production.\n- Royal Dutch Shell plc (NYSE: RDS.A) will increase because they have a lot of experience in the Venezuelan oil sector, and they are well-prepared to increase production.\n- PetroChina Company Limited (NYSE: PTR) will decrease"}, {"source": "wsj", "link": "https://www.wsj.com/articles/global-stocks-markets-dow-update-03-07-2022-11646622021", "title": "Stocks End Sharply Lower as Dow Enters Correction", "date": "2022-03-07 18:10", "summary": "Stocks drop more than 2%, Nasdaq hits a bear market as oil prices briefly rise to $130 a barrel. The Dow Jones Industrial Average slid nearly 800 points Monday, marking a 10% decline from January's high to close in correction territory for the first time in two years, as surging oil prices heightened concerns about inflation and economic growth.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Stocks End Sharply Lower as Dow Enters Correction. Stocks drop more than 2%, Nasdaq hits a bear market as oil prices briefly rise to $130 a barrel. The Dow Jones Industrial Average slid nearly 800 points Monday, marking a 10% decline from January's high to close in correction territory for the first time in two years, as surging oil prices heightened concerns about inflation and economic growth.\"\n\nStock Prediction(s):", "Prediction": "\n- All stocks will decrease because of the Dow entering correction territory.\n- Chevron Corporation (NYSE: CVX) will decrease because they are a part of the Dow.\n- Exxon Mobil Corporation (NYSE: XOM) will decrease because they are a part of the Dow.\n- Apple Inc. (NASDAQ: AAPL) will decrease because they are a part of the Dow.\n- Amazon.com, Inc. (NASDAQ: AMZN) will decrease because they are a part of the Dow."}, {"source": "wsj", "link": "https://www.wsj.com/articles/oil-ceos-biden-officials-warn-oil-volatility-is-here-to-stay-11646682826", "title": "Oil CEOs, Biden Officials Warn Oil Volatility Is Here to Stay", "date": "2022-03-07 16:40", "summary": "At industry conference in Texas, speakers caution about lack of short-term options to address rising energy prices. HOUSTON-The chief executives of some of the world's largest oil companies and U.S. government officials warned Monday that there were no quick-fix solutions to the higher energy prices and market volatility that have followed Russia's invasion of Ukraine.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Oil CEOs, Biden Officials Warn Oil Volatility Is Here to Stay. At industry conference in Texas, speakers caution about lack of short-term options to address rising energy prices. HOUSTON-The chief executives of some of the world's largest oil companies and U.S. government officials warned Monday that there were no quick-fix solutions to the higher energy prices and market volatility that have followed Russia's invasion of Ukraine.\"\n\nStock Prediction(s):", "Prediction": "\n- Chevron Corporation (NYSE: CVX) will decrease because of the volatility in the oil market.\n- Exxon Mobil Corporation (NYSE: XOM) will decrease because of the volatility in the oil market.\n- BP plc (NYSE: BP) will decrease because of the volatility in the oil market.\n- Royal Dutch Shell plc (NYSE: RDS-A) will decrease because of the volatility in the oil market."}, {"source": "wsj", "link": "https://www.wsj.com/articles/uber-raises-quarterly-guidance-on-delivery-growth-ridership-recovery-11646659359", "title": "Uber Raises Quarterly Guidance on Delivery Growth, Ridership Recovery", "date": "2022-03-07 16:38", "summary": "Chief Executive Dara Khosrowshahi says the company expects the coming travel season to be one of the strongest ever. Uber Technologies Inc. raised its first-quarter guidance Monday, saying its ride-hailing business is bouncing back quickly from the disruption caused by the spread of the Omicron variant around the end of 2021.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Uber Raises Quarterly Guidance on Delivery Growth, Ridership Recovery. Chief Executive Dara Khosrowshahi says the company expects the coming travel season to be one of the strongest ever. Uber Technologies Inc. raised its first-quarter guidance Monday, saying its ride-hailing business is bouncing back quickly from the disruption caused by the spread of the Omicron variant around the end of 2021.\"\n\nStock Prediction(s):", "Prediction": "\n- Uber Technologies Inc. (NYSE: UBER) will increase because their guidance is good and they are bouncing back from the Omicron variant.\n- Lyft Inc. (NASDAQ: LYFT) will decrease because they are a direct competitor of Uber and they have not released any good news recently."}, {"source": "wsj", "link": "https://www.wsj.com/articles/the-surge-in-gas-prices-isnt-slowing-down-11646627663", "title": "The Surge in Gasoline Prices Isn't Slowing Down", "date": "2022-03-07 16:36", "summary": "Traders and shippers are shunning Russian oil, pulling millions of barrels from global supplies and powering new increases at the pump. Prices at the gas pump are soaring to near record levels across the U.S., threatening to further pressure consumers and an economy already struggling with sky-high inflation.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"The Surge in Gasoline Prices Isn't Slowing Down. Traders and shippers are shunning Russian oil, pulling millions of barrels from global supplies and powering new increases at the pump. Prices at the gas pump are soaring to near record levels across the U.S., threatening to further pressure consumers and an economy already struggling with sky-high inflation.\"\n\nStock Prediction(s):", "Prediction": "\n- Marathon Petroleum Corporation (NYSE: MPC) will increase because they are a direct beneficiary of the high gas prices.\n- Exxon Mobil Corporation (NYSE: XOM) will decrease because they are a direct competitor of Marathon Petroleum.\n- BP plc (NYSE: BP) will decrease because they are a direct competitor of Marathon Petroleum.\n- Royal Dutch Shell plc (NYSE: RDS.A) will decrease because they are a direct competitor of Marathon Petroleum."}, {"source": "wsj", "link": "https://www.wsj.com/articles/bed-bath-beyond-stock-price-soars-premarket-on-ryan-cohens-stake-11646652094", "title": "Bed Bath & Beyond Soars After Chewy Co-Founder Takes Stake", "date": "2022-03-07 16:31", "summary": "The billionaire investor made a similar investment in GameStop before a meme-stock frenzy. Shares of Bed Bath & Beyond Inc. skyrocketed after Ryan Cohen, the billionaire co-founder of pet-supplies retailer Chewy Inc . , disclosed a 9.8% stake through his investment firm in the housewares retailer.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Bed Bath & Beyond Soars After Chewy Co-Founder Takes Stake. The billionaire investor made a similar investment in GameStop before a meme-stock frenzy. Shares of Bed Bath & Beyond Inc. skyrocketed after Ryan Cohen, the billionaire co-founder of pet-supplies retailer Chewy Inc . , disclosed a 9.8% stake through his investment firm in the housewares retailer.\"\n\nStock Prediction(s):", "Prediction": "\n- Bed Bath & Beyond Inc. (NASDAQ: BBBY) will continue to increase because the co-founder of a competing pet-supplies retailer has taken a stake in the company.\n- Chewy Inc. (private) will increase because the co-founder of a competing pet-supplies retailer has taken a stake in the company."}, {"source": "wsj", "link": "https://www.wsj.com/articles/u-s-treasurys-regain-favor-11646598110", "title": "U.S. Treasurys Regain Favor", "date": "2022-03-07 16:30", "summary": "The yield on the 10-year U.S. Treasury note has dropped to around 1.75% from 2.044% in mid-February. Russia's invasion of Ukraine and hints of slowing wage growth have driven money back into U.S. government bonds in recent days, dragging down longer-term interest rates and providing some relief to investors buffeted by declines in riskier assets.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"U.S. Treasurys Regain Favor. The yield on the 10-year U.S. Treasury note has dropped to around 1.75% from 2.044% in mid-February. Russia's invasion of Ukraine and hints of slowing wage growth have driven money back into U.S. government bonds in recent days, dragging down longer-term interest rates and providing some relief to investors buffeted by declines in riskier assets.\"\n\nStock Prediction(s):", "Prediction": "\n- The 10-year U.S. Treasury note will continue to drop because of the current global economic conditions.\n- The 30-year U.S. Treasury note will continue to drop because of the current global economic conditions.\n- The yield on the 10-year U.S. Treasury note will continue to drop because of the current global economic conditions."}, {"source": "wsj", "link": "https://www.wsj.com/articles/biden-administration-seeks-to-promote-unions-underrepresented-workers-in-infrastructure-spending-11646685940", "title": "Administration Pushes Unions, Underrepresented Workers for Infrastructure Projects", "date": "2022-03-07 16:20", "summary": "Agency guidelines would favor grant applications that make it easier for workers to join unions. The Biden administration is planning to give preference to infrastructure projects that encourage workers to unionize or that hire from underrepresented groups as it prepares to spend billions of dollars from last year's infrastructure law, administration officials said.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Administration Pushes Unions, Underrepresented Workers for Infrastructure Projects. Agency guidelines would favor grant applications that make it easier for workers to join unions. The Biden administration is planning to give preference to infrastructure projects that encourage workers to unionize or that hire from underrepresented groups as it prepares to spend billions of dollars from last year's infrastructure law, administration officials said.\"\n\nStock Prediction(s):", "Prediction": "\n- The AFL-CIO (NYSE: AFL) will increase because the administration is pushing for more unionized workers.\n- The United States Steel Corporation (NYSE: X) will increase because they are a major producer of steel, and more infrastructure projects will need steel.\n- The International Brotherhood of Electrical Workers (IBEW) (NYSE: IBEW) will increase because they represent many workers who will be hired for infrastructure projects.\n- The United Brotherhood of Carpenters and Joiners of America (NYSE: UBC) will increase because they represent many workers who will be hired for infrastructure projects."}, {"source": "wsj", "link": "https://www.wsj.com/articles/oil-industry-contemplates-world-without-russian-crude-11646662344", "title": "Oil Industry Contemplates World Without Russian Crude", "date": "2022-03-07 15:19", "summary": "Crude traders brace for disruption if Western countries ban imports of Russian oil. As oil prices shoot to levels unseen since before the 2008 financial crisis, the energy industry is asking a previously unthinkable question: How would it cope if it has to forgo Russian oil?", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Oil Industry Contemplates World Without Russian Crude. Crude traders brace for disruption if Western countries ban imports of Russian oil. As oil prices shoot to levels unseen since before the 2008 financial crisis, the energy industry is asking a previously unthinkable question: How would it cope if it has to forgo Russian oil?\"\n\nStock Prediction(s):", "Prediction": "\n- BP plc (NYSE: BP) will increase because they are one of the few companies that have the ability to replace Russian oil.\n- Royal Dutch Shell plc (NYSE: RDS.A) will increase because they are one of the few companies that have the ability to replace Russian oil.\n- Chevron Corporation (NYSE: CVX) will increase because they are one of the few companies that have the ability to replace Russian oil.\n- Exxon Mobil Corporation (NYSE: XOM) will increase because they are one of the few companies that have the ability to replace Russian oil.\n- Schlumberger Limited"}, {"source": "wsj", "link": "https://www.wsj.com/articles/what-companies-have-pulled-back-from-russia-11646425481", "title": "What Companies Have Pulled Back From Russia?", "date": "2022-03-07 13:43", "summary": "Western businesses such as Apple, Boeing and Volkswagen are re-evaluating operations in Russia after its invasion of Ukraine. Russia's invasion of Ukraine has prompted many Western companies across industries to re-evaluate their businesses in Russia. Some have decided to suspend operations in the country, while others have decided to pull out entirely.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"What Companies Have Pulled Back From Russia?. Western businesses such as Apple, Boeing and Volkswagen are re-evaluating operations in Russia after its invasion of Ukraine. Russia's invasion of Ukraine has prompted many Western companies across industries to re-evaluate their businesses in Russia. Some have decided to suspend operations in the country, while others have decided to pull out entirely.\"\n\nStock Prediction(s):", "Prediction": "\n- Apple Inc. (NASDAQ: AAPL) will decrease because they have pulled out of Russia.\n- Boeing Co. (NYSE: BA) will decrease because they have pulled out of Russia.\n- Volkswagen AG (OTCMKTS: VOW3) will decrease because they have pulled out of Russia."}, {"source": "wsj", "link": "https://www.wsj.com/articles/why-does-the-u-s-still-buy-russian-oil-11646151935", "title": "How Much Oil Does the U.S. Import From Russia?", "date": "2022-03-07 13:10", "summary": "Despite being the top global producer, the U.S. turns to Russian crude to service more-isolated coastal markets and keep refineries running at optimal levels. The fracking boom made America the world's biggest oil producer a few years ago, but the U.S. still imports millions of barrels each day from other parts of the world, including Russia.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"How Much Oil Does the U.S. Import From Russia?. Despite being the top global producer, the U.S. turns to Russian crude to service more-isolated coastal markets and keep refineries running at optimal levels. The fracking boom made America the world's biggest oil producer a few years ago, but the U.S. still imports millions of barrels each day from other parts of the world, including Russia.\"\n\nStock Prediction(s):", "Prediction": "\n- Exxon Mobil Corporation (NYSE: XOM) will increase because they are one of the few companies that can service the more-isolated coastal markets.\n- Chevron Corporation (NYSE: CVX) will increase because they are one of the few companies that can service the more-isolated coastal markets.\n- Marathon Petroleum Corporation (NYSE: MPC) will increase because they are one of the few companies that can service the more-isolated coastal markets.\n- Royal Dutch Shell plc (NYSE: RDS.A) will increase because they are one of the few companies that can service the more-isolated"}, {"source": "wsj", "link": "https://www.wsj.com/articles/ai-will-evaluate-your-job-application-do-you-still-want-to-apply-11646431306", "title": "AI Will Evaluate Your Job Application. Do You Still Want to Apply?", "date": "2022-03-07 12:00", "summary": "A study suggests that the answer may depend on how artificial intelligence is used. If job seekers knew companies were using artificial intelligence to fill open positions, would it stop them from applying for the job?", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"AI Will Evaluate Your Job Application. Do You Still Want to Apply?. A study suggests that the answer may depend on how artificial intelligence is used. If job seekers knew companies were using artificial intelligence to fill open positions, would it stop them from applying for the job?\"\n\nStock Prediction(s):", "Prediction": "\n- IBM Corporation (NYSE: IBM) will increase because they are a leader in artificial intelligence and will be able to help companies fill open positions more efficiently.\n- Amazon.com, Inc. (NASDAQ: AMZN) will increase because they are a leader in artificial intelligence and will be able to help companies fill open positions more efficiently.\n- Microsoft Corporation (NASDAQ: MSFT) will increase because they are a leader in artificial intelligence and will be able to help companies fill open positions more efficiently.\n- Google Inc. (NASDAQ: GOOGL) will increase because they are a leader in artificial intelligence"}, {"source": "wsj", "link": "https://www.wsj.com/articles/activist-william-ackman-takes-stake-in-canadian-pacific-11646671278", "title": "William Ackman Acquires Stake in Canadian Pacific", "date": "2022-03-07 11:41", "summary": "Investment worth more than $1 billion marks a return to railroad for billionaire. Billionaire investor William Ackman acquired a stake in Canadian Pacific Railway Ltd. as the railroad seeks regulatory approval for its proposed $27 billion merger with Kansas City Southern.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"William Ackman Acquires Stake in Canadian Pacific. Investment worth more than $1 billion marks a return to railroad for billionaire. Billionaire investor William Ackman acquired a stake in Canadian Pacific Railway Ltd. as the railroad seeks regulatory approval for its proposed $27 billion merger with Kansas City Southern.\"\n\nStock Prediction(s):", "Prediction": "\n- Canadian Pacific Railway Ltd. (NYSE: CP) will increase because they have a new investor, and they are in the process of a merger.\n- Kansas City Southern (NYSE: KSU) will decrease because they are in a competitive market, and they may not be able to keep up with the larger Canadian Pacific Railway Ltd."}, {"source": "wsj", "link": "https://www.wsj.com/articles/bed-bath-beyond-goes-to-the-moon-11646670877", "title": "Bed Bath & Beyond Goes to the Moon", "date": "2022-03-07 11:34", "summary": "Shares surged after GameStop chairman disclosed stake in struggling retailer. Diamond hands might be a struggling retailer's best friend.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Bed Bath & Beyond Goes to the Moon. Shares surged after GameStop chairman disclosed stake in struggling retailer. Diamond hands might be a struggling retailer's best friend.\"\n\nStock Prediction(s):", "Prediction": "\n- Bed Bath & Beyond Inc. (NASDAQ: BBBY) will increase because a major shareholder has bought in, giving the company a vote of confidence.\n- GameStop Corp. (NYSE: GME) will increase because a major shareholder has bought in, giving the company a vote of confidence.\n- Sears Holdings Corp. (NASDAQ: SHLD) will decrease because it is in a downward spiral and no one wants to invest in it anymore."}, {"source": "wsj", "link": "https://www.wsj.com/articles/big-auditors-to-leave-russia-amid-invasion-of-ukraine-11646666419", "title": "Big Auditors to Leave Russia", "date": "2022-03-07 10:20", "summary": "All four top accounting firms are cutting ties with their Russian operations. The Big Four accounting firms are cutting ties with their Russian operations, walking away from businesses built up over decades that between them employ more than 15,900 people.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Big Auditors to Leave Russia. All four top accounting firms are cutting ties with their Russian operations. The Big Four accounting firms are cutting ties with their Russian operations, walking away from businesses built up over decades that between them employ more than 15,900 people.\"\n\nStock Prediction(s):", "Prediction": "\n- Deloitte Touche Tohmatsu Ltd. (NYSE: DLTE) will decrease because they are one of the Big Four accounting firms that is leaving Russia.\n- Ernst & Young Global Ltd. (NYSE: EY) will decrease because they are one of the Big Four accounting firms that is leaving Russia.\n- KPMG International Cooperative (NYSE: KPMG) will decrease because they are one of the Big Four accounting firms that is leaving Russia.\n- PricewaterhouseCoopers International Limited (NYSE: PWC) will decrease because they are one of the Big Four accounting firms that is leaving Russia"}, {"source": "wsj", "link": "https://www.wsj.com/articles/should-amazon-google-microsoft-cloud-companies-face-more-government-oversight-11646430816", "title": "Should Amazon, Microsoft, Google and Other Cloud Companies Face More Government Oversight?", "date": "2022-03-07 10:00", "summary": "Individuals and companies depend on their services. But they are more lightly regulated than other crucial industries. Three experts debate their future.. Cloud-computing services are so ubiquitous that it's hard to fathom modern life without them.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Should Amazon, Microsoft, Google and Other Cloud Companies Face More Government Oversight?. Individuals and companies depend on their services. But they are more lightly regulated than other crucial industries. Three experts debate their future.. Cloud-computing services are so ubiquitous that it's hard to fathom modern life without them.\"\n\nStock Prediction(s):", "Prediction": "\n- Amazon.com, Inc. (NASDAQ: AMZN) will increase because they are one of the main providers of cloud-computing services, and they are more lightly regulated than other companies.\n- Microsoft Corporation (NASDAQ: MSFT) will increase because they are one of the main providers of cloud-computing services, and they are more lightly regulated than other companies.\n- Alphabet Inc. (NASDAQ: GOOGL) will increase because they are one of the main providers of cloud-computing services, and they are more lightly regulated than other companies.\n- Oracle Corporation (NYSE:"}, {"source": "wsj", "link": "https://www.wsj.com/articles/replacing-russian-gas-in-europe-will-require-state-planning-11646665213", "title": "Replacing Russian Gas in Europe Will Require State Planning", "date": "2022-03-07 10:00", "summary": "European Union wants to speed up its green path to energy security, but it is up to individual countries to outline solid plans that cut the risk for investors. The war in Ukraine has ended the notion that natural gas is a reliable transition fuel for Europe, but it will still need to rely on it for years to come.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Replacing Russian Gas in Europe Will Require State Planning. European Union wants to speed up its green path to energy security, but it is up to individual countries to outline solid plans that cut the risk for investors. The war in Ukraine has ended the notion that natural gas is a reliable transition fuel for Europe, but it will still need to rely on it for years to come.\"\n\nStock Prediction(s):", "Prediction": "\n- Gazprom PJSC (OTC: OGZPY) will increase because they are the main supplier of natural gas to Europe, and they will be needed more than ever now that the war in Ukraine has ended.\n- Royal Dutch Shell plc (NYSE: RDS.A) will increase because they are a major supplier of natural gas to Europe, and they will be needed more than ever now that the war in Ukraine has ended.\n- Exxon Mobil Corporation (NYSE: XOM) will decrease because they are not a major supplier of natural gas to Europe, and they will be less needed now that the war"}, {"source": "wsj", "link": "https://www.wsj.com/articles/greg-kelly-former-nissan-executive-in-ghosn-case-returns-to-u-s-after-three-years-in-japan-11646664698", "title": "Former Nissan Executive in Ghosn Case Returns to U.S.", "date": "2022-03-07 09:51", "summary": "Suspended sentence handed down by Tokyo court allows Kelly to return home to Tennessee. TOKYO-Former Nissan Motor Co. executive Greg Kelly flew back to the U.S. from Japan on Monday, ending a Tokyo stay that he thought would take just a few days but ended up lasting more than three years.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Former Nissan Executive in Ghosn Case Returns to U.S.. Suspended sentence handed down by Tokyo court allows Kelly to return home to Tennessee. TOKYO-Former Nissan Motor Co. executive Greg Kelly flew back to the U.S. from Japan on Monday, ending a Tokyo stay that he thought would take just a few days but ended up lasting more than three years.\"\n\nStock Prediction(s):", "Prediction": "\n- Nissan Motor Co., Ltd. (OTCPK: NSANY) will increase because their former executive is returning home, and they are no longer embroiled in the Ghosn case.\n- Renault SA (OTCPK: RNLSY) will increase because their former executive is returning home, and they are no longer embroiled in the Ghosn case.\n- Mitsubishi Motors Corporation (OTCPK: MMTOF) will increase because their former executive is returning home, and they are no longer embroiled in the Ghosn case.\n- Ford Motor Company (NYSE: F) will decrease because they"}, {"source": "wsj", "link": "https://www.wsj.com/articles/oasis-whiting-near-all-stock-merger-11646612476", "title": "Oasis, Whiting Reach Deal to Merge", "date": "2022-03-07 09:47", "summary": "Deal between rival North Dakota shale drillers would form company valued at $6 billion including debt. Rival North Dakota shale drillers Oasis Petroleum Inc. and Whiting Petroleum Corp. said Monday they have reached a deal to merge, forming a combined company that they valued at $6 billion including debt.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Oasis, Whiting Reach Deal to Merge. Deal between rival North Dakota shale drillers would form company valued at $6 billion including debt. Rival North Dakota shale drillers Oasis Petroleum Inc. and Whiting Petroleum Corp. said Monday they have reached a deal to merge, forming a combined company that they valued at $6 billion including debt.\"\n\nStock Prediction(s):", "Prediction": "\n- Oasis Petroleum Inc. (NYSE: OAS) will increase because they are merging with a rival company, and they will have a larger market share.\n- Whiting Petroleum Corp. (NYSE: WLL) will decrease because they are merging with a rival company, and they will have a smaller market share.\n- Marathon Oil Corporation (NYSE: MRO) will decrease because they are not merging with anyone, and they will have a smaller market share."}, {"source": "wsj", "link": "https://www.wsj.com/articles/facebook-gains-inside-role-in-u-s-250th-anniversary-project-with-10-million-agreement-11646661642", "title": "Facebook Gains Inside Role in U.S. 250th Anniversary Project", "date": "2022-03-07 09:00", "summary": "Organization torn over Meta deal that some staffers worry will put off other potential corporate sponsors. WASHINGTON-The America250 Foundation, a nonprofit planning the government's observance of the American Revolution's 250th anniversary, has signed a deal with Meta Platforms Inc. giving Facebook 's parent an inside role in producing and promoting the Semiquincentennial commemoration in exchange for $10 million, according to documents viewed by The Wall Street Journal and confirmed by the company.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Facebook Gains Inside Role in U.S. 250th Anniversary Project. Organization torn over Meta deal that some staffers worry will put off other potential corporate sponsors. WASHINGTON-The America250 Foundation, a nonprofit planning the government's observance of the American Revolution's 250th anniversary, has signed a deal with Meta Platforms Inc. giving Facebook 's parent an inside role in producing and promoting the Semiquincentennial commemoration in exchange for $10 million, according to documents viewed by The Wall Street Journal and confirmed by the company.\"\n\nStock Prediction(s):", "Prediction": "\n- Facebook, Inc. (NASDAQ: FB) will increase because they are gaining an inside role in the U.S. 250th Anniversary project, and they are donating $10 million.\n- Meta Platforms Inc. (OTCQB: META) will increase because they are the company that Facebook is working with, and they are receiving $10 million.\n- Other potential corporate sponsors will be scared away because Facebook and Meta Platforms have already partnered up."}, {"source": "wsj", "link": "https://www.wsj.com/articles/as-war-looms-shipping-stocks-might-sink-not-swim-11646655187", "title": "Shipping Stocks Might Sink Not Swim", "date": "2022-03-07 08:32", "summary": "War in Ukraine has contradictory impacts on shippers and shipping rates. But the biggest story of 2022 will still probably be the tapering off of enormous goods demand.. For global shipping companies that spent the past year feasting on insatiable demand for their services, the party must end sooner or later. The Russia-Ukraine war is putting pressure on the shipping lines with delivery disruptions and rerouting of cargo. But the big story remains the normalization of U.S. demand as stimulus fades and the waning Omicron wave pushes global consumption back toward services, which appears to already be weighing on some shipping rates.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Shipping Stocks Might Sink Not Swim. War in Ukraine has contradictory impacts on shippers and shipping rates. But the biggest story of 2022 will still probably be the tapering off of enormous goods demand.. For global shipping companies that spent the past year feasting on insatiable demand for their services, the party must end sooner or later. The Russia-Ukraine war is putting pressure on the shipping lines with delivery disruptions and rerouting of cargo. But the big story remains the normalization of U.S. demand as stimulus fades and the waning Omicron wave pushes global consumption back toward services, which appears to already be weighing on some shipping rates.\"\n\nStock Prediction(s):", "Prediction": "\n- Maersk Line A/S (MAERSK B) will decrease because of the war in Ukraine and the tapering off of enormous goods demand.\n- Mediterranean Shipping Company S.A. (MSC) will decrease because of the war in Ukraine and the tapering off of enormous goods demand.\n- COSCO SHIPPING Holdings Co., Ltd. (COSCO) will decrease because of the war in Ukraine and the tapering off of enormous goods demand.\n- Hapag-Lloyd AG (HLAG) will decrease because of the war in Ukraine and the tapering off of"}, {"source": "wsj", "link": "https://www.wsj.com/articles/russian-aluminum-giants-owner-considers-splitting-foreign-operations-11646651556", "title": "Russian Aluminum Giant's Owner Considers Splitting Foreign Operations", "date": "2022-03-07 06:12", "summary": "EN+ reviews Rusal strategy in wake of Russia's invasion of Ukraine. The controlling shareholder of Rusal , Russia's largest aluminum producer, said it was exploring a separation of the company's international operations and that its British chairman was stepping down.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Russian Aluminum Giant's Owner Considers Splitting Foreign Operations. EN+ reviews Rusal strategy in wake of Russia's invasion of Ukraine. The controlling shareholder of Rusal , Russia's largest aluminum producer, said it was exploring a separation of the company's international operations and that its British chairman was stepping down.\"\n\nStock Prediction(s):", "Prediction": "\n- United Company Rusal Plc (OTC: UCRLY) will decrease because their chairman is stepping down, and they may be splitting their foreign operations.\n- Glencore Plc (OTC: GLCNF) will increase because they are a competitor of United Company Rusal Plc, and they may be getting more business as a result."}, {"source": "wsj", "link": "https://www.wsj.com/articles/boeings-future-with-a-titanium-venture-in-russia-remains-cloudy-11646649002", "title": "Boeing's Big Bet on Russian Titanium Includes Ties to Sanctioned Oligarch", "date": "2022-03-07 05:30", "summary": "Plane maker has suspended buying the metal from Russia but must still deal with ties with company linked to sanctioned oligarch and Putin ally. Boeing Co. has suspended parts of its business in Russia, but it still has to deal with its relationship to a key titanium supplier led by a sanctioned oligarch who once worked in the KGB with President Vladimir Putin.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Boeing's Big Bet on Russian Titanium Includes Ties to Sanctioned Oligarch. Plane maker has suspended buying the metal from Russia but must still deal with ties with company linked to sanctioned oligarch and Putin ally. Boeing Co. has suspended parts of its business in Russia, but it still has to deal with its relationship to a key titanium supplier led by a sanctioned oligarch who once worked in the KGB with President Vladimir Putin.\"\n\nStock Prediction(s):", "Prediction": "\n- Boeing Co. (NYSE: BA) will decrease because of their business dealings with a sanctioned oligarch.\n- United Technologies Corp. (NYSE: UTX) will decrease because of their business dealings with a sanctioned oligarch.\n- Honeywell International Inc. (NYSE: HON) will decrease because of their business dealings with a sanctioned oligarch."}, {"source": "wsj", "link": "https://www.wsj.com/articles/u-s-retirement-funds-heavy-on-stocks-brace-for-losses-11646601597", "title": "U.S. Retirement Funds Brace for Losses", "date": "2022-03-07 05:30", "summary": "A sustained downturn could squeeze state and local government budgets. Volatile stock markets are eroding the retirement savings of America's teachers and firefighters after public pension systems ended last year with equity holdings at a 10-year high.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"U.S. Retirement Funds Brace for Losses. A sustained downturn could squeeze state and local government budgets. Volatile stock markets are eroding the retirement savings of America's teachers and firefighters after public pension systems ended last year with equity holdings at a 10-year high.\"\n\nStock Prediction(s):", "Prediction": "\n- State and local government budgets will be squeezed, and they will have to cut back on other programs in order to make up for the losses in the retirement funds.\n- Teachers and firefighters will have to tighten their belts, and may have to delay their retirement plans.\n- The stock market will continue to be volatile, which will cause more losses in the retirement funds."}, {"source": "wsj", "link": "https://www.wsj.com/articles/hong-kongs-hang-seng-hits-five-year-low-11646648450", "title": "Hong Kong's Hang Seng Hits Five-Year Low", "date": "2022-03-07 05:20", "summary": "Some indexes in mainland China close at levels last registered in 2020. Hong Kong's Hang Seng Index dropped 3.9% Monday to close at its lowest since July 2016, as an international selloff fueled by the war in Ukraine put fresh pressure on a market already suffering from Beijing's corporate crackdowns and tough local pandemic policies.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Hong Kong's Hang Seng Hits Five-Year Low. Some indexes in mainland China close at levels last registered in 2020. Hong Kong's Hang Seng Index dropped 3.9% Monday to close at its lowest since July 2016, as an international selloff fueled by the war in Ukraine put fresh pressure on a market already suffering from Beijing's corporate crackdowns and tough local pandemic policies.\"\n\nStock Prediction(s):", "Prediction": "\n- Hang Seng Index will continue to decrease because of the war in Ukraine, Beijing's corporate crackdowns, and tough local pandemic policies.\n- Alibaba Group Holding Ltd (NYSE: BABA) will increase because they are not affected by the same issues as the Hang Seng Index.\n- Tencent Holdings Ltd (OTCMKTS: TCEHY) will increase because they are not affected by the same issues as the Hang Seng Index."}, {"source": "wsj", "link": "https://www.wsj.com/articles/tom-cotton-to-compare-reagan-and-trump-in-speech-on-future-of-the-gop-11646647200", "title": "Tom Cotton to Compare Reagan and Trump in Speech on GOP's Future", "date": "2022-03-07 05:00", "summary": "Arkansas senator and possible 2024 presidential candidate is the latest in a series of Reagan Library speakers. Sen. Tom Cotton of Arkansas is expected to argue in a high-profile speech Monday evening that presidents Ronald Reagan and Donald Trump share common roots in the Republican Party and that those who suggest the GOP must pick a path that embraces one or the other are wrong.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Tom Cotton to Compare Reagan and Trump in Speech on GOP's Future. Arkansas senator and possible 2024 presidential candidate is the latest in a series of Reagan Library speakers. Sen. Tom Cotton of Arkansas is expected to argue in a high-profile speech Monday evening that presidents Ronald Reagan and Donald Trump share common roots in the Republican Party and that those who suggest the GOP must pick a path that embraces one or the other are wrong.\"\n\nStock Prediction(s):", "Prediction": "\n- The Republican Party will increase in popularity because Tom Cotton is arguing that they share common roots with Ronald Reagan and Donald Trump.\n- The Democratic Party will decrease in popularity because Tom Cotton is arguing that they are wrong to suggest that the GOP must pick a path that embraces one or the other."}, {"source": "wsj", "link": "https://www.wsj.com/articles/russia-recruiting-syrians-for-urban-combat-in-ukraine-u-s-officials-say-11646606234", "title": "Russia Recruiting Syrians for Urban Combat in Ukraine, U.S. Officials Say", "date": "2022-03-07 20:47", "summary": "Moscow is looking for help from foreign fighters to take cities including Kyiv. WASHINGTON-Moscow is recruiting Syrians skilled in urban combat to fight in Ukraine as Russia's invasion is poised to expand deeper into cities, according to U.S. officials.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Russia Recruiting Syrians for Urban Combat in Ukraine, U.S. Officials Say. Moscow is looking for help from foreign fighters to take cities including Kyiv. WASHINGTON-Moscow is recruiting Syrians skilled in urban combat to fight in Ukraine as Russia's invasion is poised to expand deeper into cities, according to U.S. officials.\"\n\nStock Prediction(s):", "Prediction": "\n- Russia (MCX: RSX) will increase because they are expanding their invasion deeper into cities.\n- The United States (NYSE: USD) will increase because they are helping to fight the Russians.\n- Ukraine (UX) will increase because they are being invaded by the Russians.\n- European Union (EUR) will decrease because of the Russian invasion."}, {"source": "wsj", "link": "https://www.wsj.com/articles/land-buildings-nominates-founder-litt-to-ventas-board-11646607600", "title": "Land & Buildings Nominates Founder Litt to Ventas Board", "date": "2022-03-07 20:33", "summary": "The real-estate focused investment firm owns roughly $50 million of the healthcare REIT's shares. A shareholder activist is pushing to join the board of Ventas Inc., arguing the healthcare real-estate investment trust would benefit from an investor's perspective.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Land & Buildings Nominates Founder Litt to Ventas Board. The real-estate focused investment firm owns roughly $50 million of the healthcare REIT's shares. A shareholder activist is pushing to join the board of Ventas Inc., arguing the healthcare real-estate investment trust would benefit from an investor's perspective.\"\n\nStock Prediction(s):", "Prediction": "\n- Ventas, Inc. (NYSE: VTR) will increase because they are being proactive about their shareholders and are open to new ideas.\n- Land & Buildings Investment Management, LLC (NYSE: LAND) will increase because they are nominating a representative to the Ventas board."}, {"source": "wsj", "link": "https://www.wsj.com/articles/oil-buyers-paying-record-premiums-for-prompt-deliveries-11646518865", "title": "Oil Tops $130 a Barrel as Russian Attacks Escalate", "date": "2022-03-07 19:24", "summary": "Buyers are bidding up prompt crude deliveries to replace Russian barrels. Oil buyers racing to replace Russia' taboo crude are paying record premiums for barrels that can be delivered now rather than later, reflecting worries about adequate near-term fuel supplies and expectations that high prices will reduce consumption and encourage drilling.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Oil Tops $130 a Barrel as Russian Attacks Escalate. Buyers are bidding up prompt crude deliveries to replace Russian barrels. Oil buyers racing to replace Russia' taboo crude are paying record premiums for barrels that can be delivered now rather than later, reflecting worries about adequate near-term fuel supplies and expectations that high prices will reduce consumption and encourage drilling.\"\n\nStock Prediction(s):", "Prediction": "\n- Chevron Corporation (NYSE: CVX) will increase because they are a direct competitor of Russian oil companies and they will benefit from the high oil prices.\n- Exxon Mobil Corporation (NYSE: XOM) will increase because they are a direct competitor of Russian oil companies and they will benefit from the high oil prices.\n- Royal Dutch Shell plc (NYSE: RDS.A) will increase because they are a direct competitor of Russian oil companies and they will benefit from the high oil prices.\n- BP plc (NYSE: BP) will increase because they are a direct competitor of Russian oil companies and they will benefit"}, {"source": "wsj", "link": "https://www.wsj.com/articles/gamestop-chairman-ryan-cohen-takes-large-stake-in-bed-bath-beyond-pushes-for-changes-11646611200", "title": "Chewy Co-Founder Ryan Cohen Takes Large Stake in Bed Bath & Beyond", "date": "2022-03-07 19:06", "summary": "Billionaire investor wants the chain to simplify its turnaround plan and consider a sale or separation of Buybuy Baby. Ryan Cohen, the billionaire co-founder of online pet-products retailer Chewy Inc., has a big stake in Bed Bath & Beyond Inc. and is pushing the housewares retailer to streamline its strategy and explore strategic alternatives.", "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s):\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Chewy Co-Founder Ryan Cohen Takes Large Stake in Bed Bath & Beyond. Billionaire investor wants the chain to simplify its turnaround plan and consider a sale or separation of Buybuy Baby. Ryan Cohen, the billionaire co-founder of online pet-products retailer Chewy Inc., has a big stake in Bed Bath & Beyond Inc. and is pushing the housewares retailer to streamline its strategy and explore strategic alternatives.\"\n\nStock Prediction(s):", "Prediction": "\n- Bed Bath & Beyond Inc. (NASDAQ: BBBY) will increase because they are being pushed by a major investor to simplify their turnaround plan and consider a sale or separation of Buybuy Baby.\n- Chewy Inc. (NASDAQ: CHWY) will increase because Ryan Cohen, the co-founder, has a large stake in the company and is pushing Bed Bath & Beyond to consider a sale or separation of Buybuy Baby."}]